ABT
Abbott Laboratories
NYSE: ABT · HEALTHCARE · MEDICAL DEVICES
$90.79
-0.59% today
Updated 2026-04-30
Market cap
$158.70B
P/E ratio
25.58
P/S ratio
3.52x
EPS (TTM)
$3.57
Dividend yield
2.60%
52W range
$90 – $136
Volume
11.9M
Abbott Laboratories (ABT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.48B | $25.91B | $29.53B | $30.77B | $35.17B | $38.85B | $39.87B | $21.85B | $20.25B | $20.41B | $20.85B | $27.39B | $30.58B | $31.90B | $34.61B | $43.08B | $43.65B | $40.11B | $41.95B | $44.33B |
| Revenue growth (YoY) | — | +15.3% | +13.9% | +4.2% | +14.3% | +10.5% | +2.6% | -45.2% | -7.3% | +0.8% | +2.2% | +31.3% | +11.6% | +4.3% | +8.5% | +24.5% | +1.3% | -8.1% | +4.6% | +5.7% |
| Cost of revenue | $9.63B | $11.33B | $12.48B | $13.15B | $14.57B | $15.41B | $10.64B | $9.80B | $9.76B | $9.45B | $9.61B | $14.32B | $14.76B | $15.21B | $17.23B | $19.86B | $21.33B | $20.07B | $20.63B | $19.72B |
| Gross profit | $12.84B | $14.59B | $17.04B | $17.62B | $20.59B | $23.44B | $10.85B | $9.86B | $10.49B | $10.96B | $11.24B | $13.07B | $15.82B | $16.69B | $17.38B | $23.21B | $22.32B | $20.04B | $21.32B | $24.61B |
| Gross margin | 57.1% | 56.3% | 57.7% | 57.3% | 58.6% | 60.3% | 27.2% | 45.1% | 51.8% | 53.7% | 53.9% | 47.7% | 51.7% | 52.3% | 50.2% | 53.9% | 51.1% | 50.0% | 50.8% | 55.5% |
| R&D | $2.23B | $2.40B | $2.69B | $2.74B | $3.57B | $4.06B | $1.54B | $1.37B | $1.29B | $1.37B | $1.36B | $2.13B | $2.29B | $2.41B | $2.42B | $2.74B | $2.85B | $2.72B | $2.82B | $2.96B |
| SG&A | $6.35B | $7.41B | $8.44B | $8.41B | $10.38B | $12.76B | $12.06B | $6.94B | $6.53B | $6.79B | $6.67B | $9.12B | $9.74B | $9.77B | $9.70B | $11.32B | $11.01B | $11.20B | $11.70B | $12.38B |
| Operating income | $4.34B | $4.95B | $6.09B | $6.57B | $7.05B | $6.84B | $2.01B | $2.15B | $2.92B | $2.95B | $3.25B | $1.97B | $3.84B | $4.59B | $5.29B | $9.20B | $8.36B | $6.43B | $6.83B | $8.05B |
| Operating margin | 19.3% | 19.1% | 20.6% | 21.4% | 20.0% | 17.6% | 5.0% | 9.8% | 14.4% | 14.5% | 15.6% | 7.2% | 12.6% | 14.4% | 15.3% | 21.4% | 19.2% | 16.0% | 16.3% | 18.2% |
| EBITDA | $4.25B | $6.92B | $8.22B | $9.49B | $9.14B | $9.26B | $3.50B | $3.60B | $4.16B | $4.83B | $3.07B | $6.13B | $6.88B | $7.91B | $9.00B | $12.16B | $11.89B | $10.61B | $10.83B | $11.55B |
| EBITDA margin | 18.9% | 26.7% | 27.9% | 30.9% | 26.0% | 23.8% | 8.8% | 16.5% | 20.5% | 23.7% | 14.7% | 22.4% | 22.5% | 24.8% | 26.0% | 28.2% | 27.2% | 26.4% | 25.8% | 26.1% |
| EBIT | $2.69B | $5.06B | $6.38B | $7.40B | $6.51B | $6.22B | $712.79M | $2.09B | $2.68B | $3.36B | $1.72B | $3.11B | $3.60B | $4.89B | $5.68B | $8.62B | $8.62B | $7.36B | $7.62B | $8.81B |
| Interest expense | $416.17M | $593.14M | $528.47M | $210.66M | $801.13M | $1.02B | $409.00M | $47.00M | $164.00M | $178.00M | $304.00M | $880.00M | $729.00M | $818.00M | $708.00M | $410.00M | $315.00M | $698.00M | $603.00M | $341.00M |
| Income tax | $559.62M | $863.33M | $1.12B | $1.45B | $1.09B | $470.00M | $300.00M | $138.00M | $797.00M | $577.00M | $350.00M | $1.88B | $539.00M | $390.00M | $497.00M | $1.14B | $1.37B | $941.00M | $-6.39B | $1.94B |
| Effective tax rate | 24.6% | 19.3% | 18.7% | 20.1% | 19.0% | 9.0% | 4.8% | 5.1% | 25.9% | 11.5% | 20.0% | 79.7% | 18.5% | 9.6% | 10.0% | 13.9% | 16.5% | 14.1% | -91.1% | 22.9% |
| Net income | $1.72B | $3.61B | $4.88B | $5.75B | $4.63B | $4.73B | $5.96B | $2.58B | $2.28B | $4.42B | $1.40B | $477.00M | $2.37B | $3.69B | $4.50B | $7.07B | $6.93B | $5.72B | $13.40B | $6.52B |
| Net income growth (YoY) | — | +110.1% | +35.3% | +17.7% | -19.5% | +2.2% | +26.1% | -56.8% | -11.3% | +93.7% | -68.3% | -65.9% | +396.4% | +55.7% | +21.9% | +57.3% | -2.0% | -17.5% | +134.2% | -51.3% |
| Profit margin | 7.6% | 13.9% | 16.5% | 18.7% | 13.2% | 12.2% | 15.0% | 11.8% | 11.3% | 21.7% | 6.7% | 1.7% | 7.7% | 11.6% | 13.0% | 16.4% | 15.9% | 14.3% | 31.9% | 14.7% |